Research

The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study

Behnaz Schofield, Clive Gregory, Micaela Gal, David Gillespie, Gurudutt Naik, Alastair Hay and Nick Francis
BJGP Open 2020; 4 (2): bjgpopen20X101006. DOI: https://doi.org/10.3399/bjgpopen20X101006
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson{at}gmail.com. PLEASE NOTE: your email address will be published.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

BJGP Open
Vol. 4, Issue 2
June 2020
Download PDF
Download PowerPoint
Email Article
Citation Tools
The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
Behnaz Schofield, Clive Gregory, Micaela Gal, David Gillespie, Gurudutt Naik, Alastair Hay, Nick Francis
BJGP Open 2020; 4 (2): bjgpopen20X101006. DOI: 10.3399/bjgpopen20X101006
del.icio.us logo Facebook logo Mendeley logo Bluesky logo

Jump to section

Keywords

Intended for Healthcare Professionals
 
 

British Journal of General Practice